RegentAtlantic Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.32M | Sell |
11,193
-3,136
| -22% | -$371K | 0.04% | 261 |
|
|
2022
Q2 | $2.05M | Buy |
14,329
+72
| +0.5% | +$10.3K | 0.07% | 209 |
|
|
2022
Q1 | $2.46M | Buy |
14,257
+3,813
| +37% | +$657K | 0.07% | 199 |
|
|
2021
Q4 | $2.65M | Sell |
10,444
-3,008
| -22% | -$764K | 0.07% | 183 |
|
|
2021
Q3 | $5.18M | Buy |
13,452
+12,135
| +921% | +$4.67M | 0.16% | 108 |
|
|
2021
Q2 | $309K | Buy |
+1,317
| New | +$309K | 0.01% | 523 |
|
|
2021
Q1 | – | Sell |
-4,946
| Closed | -$517K | – | 552 |
|
|
2020
Q4 | $517K | Sell |
4,946
-1,535
| -24% | -$160K | 0.02% | 335 |
|
|
2020
Q3 | $459K | Sell |
6,481
-2
| -0% | -$142 | 0.02% | 337 |
|
|
2020
Q2 | $416K | Sell |
6,483
-4,054
| -38% | -$260K | 0.02% | 330 |
|
|
2020
Q1 | $316K | Sell |
10,537
-3,896
| -27% | -$117K | 0.02% | 326 |
|
|
2019
Q4 | $282K | Sell |
14,433
-2,000
| -12% | -$39.1K | 0.02% | 390 |
|
|
2019
Q3 | $262K | Sell |
16,433
-3,000
| -15% | -$47.8K | 0.02% | 387 |
|
|
2019
Q2 | $284K | Buy |
+19,433
| New | +$284K | 0.02% | 371 |
|